GBT
Global Blood Therapeutics, Inc.
Delisted
GBT was delisted on the 4th of October, 2022.
190 hedge funds and large institutions have $2.25B invested in Global Blood Therapeutics, Inc. in 2021 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 81 increasing their positions, 56 reducing their positions, and 41 closing their positions.
Holders
190
Holders Change
-23
Holders Change %
-10.8%
% of All Funds
3.32%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.09%
New
19
Increased
81
Reduced
56
Closed
41
Calls
$59.8M
Puts
$11.2M
Net Calls
+$48.6M
Net Calls Change
+$51.4M
Top Buyers
| 1 |
1
BlackRock
New York
|
$202M |
| 2 |
2
Point72 Asset Management
Stamford,
Connecticut
|
$72.2M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$80.6M |
| 4 |
CC
4
Casdin Capital
New York
|
$45.9M |
| 5 |
5
Morgan Stanley
New York
|
$19.3M |
